omega-n-methylarginine has been researched along with amylopectin in 1 studies
Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (amylopectin) | Trials (amylopectin) | Recent Studies (post-2010) (amylopectin) |
---|---|---|---|---|---|
4,411 | 344 | 336 | 1,342 | 25 | 782 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akkayagil, E; Fink, L; Ghofrani, HA; Grimminger, F; Hänze, J; Quanz, K; Rose, F; Schermuly, RT; Seeger, W; Weissmann, N | 1 |
1 other study(ies) available for omega-n-methylarginine and amylopectin
Article | Year |
---|---|
Basic features of hypoxic pulmonary vasoconstriction in mice.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amylopectin; Animals; Aspirin; Blood Pressure; Drug Interactions; Enzyme Inhibitors; Hypoxia; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; omega-N-Methylarginine; Oxygen; Pulmonary Artery; Pulmonary Circulation; Pulmonary Gas Exchange; Species Specificity; Tidal Volume; Vasoconstriction; Vasoconstrictor Agents | 2004 |